ANI Pharmaceuticals Inc. (ANIP)
68.38
1.21 (1.80%)
At close: Mar 27, 2025, 3:59 PM
73.74
7.83%
After-hours: Mar 27, 2025, 06:29 PM EDT
ANI Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Revenue | 614.38M | 486.82M | 316.38M | 216.14M | 208.47M | 206.55M | 201.58M | 176.84M | 128.62M | 76.32M | 55.97M | 30.08M | 2.3M | 435.16K | 2.47M | 1.26M | 3.78M | 493.05K | 14.44M | 258.35K | 77.89K | 65.49K | 2.83M | 1.75M | 2.00 | 1.00 | 123.06K |
| Cost of Revenue | n/a | 181.51M | 138.78M | 100.61M | 87.16M | 63.15M | 73.02M | 79.03M | 48.78M | 12.69M | 11.47M | 9.97M | 9.17M | 50K | 268.75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.29K | n/a | n/a |
| Gross Profit | 614.38M | 305.3M | 177.6M | 115.53M | 121.32M | 143.39M | 128.55M | 97.81M | 79.84M | 63.63M | 44.5M | 20.11M | -6.87M | 385.16K | 2.21M | 1.26M | 3.78M | 493.05K | 14.44M | 258.35K | 77.89K | 65.49K | 2.83M | 1.75M | 24.29K | 1.00 | 123.06K |
| Operating Income | 584K | 46.97M | -25.06M | -32.51M | -16.06M | 16.35M | 35.36M | 28.33M | 20.08M | 32.7M | 20.01M | 898K | -23.17M | -50.93M | -43.61M | -38.43M | -18.01M | -8.68M | 3.44M | -9.3M | -12.27M | -6.05M | -3.81M | -2.79M | -3.66M | -1.6M | -2.66M |
| Interest Income | n/a | n/a | 28.05M | 11.92M | 9.45M | 12.97M | n/a | n/a | n/a | n/a | n/a | n/a | 8.54K | 8.33K | 12.66K | 11.65K | 588.46K | 1.1M | 428.34K | 401.19K | 250.42K | 86.59K | 63.79K | 174.42K | 227.72K | n/a | n/a |
| Pretax Income | -22.21M | 19.87M | -62.66M | -56.06M | -25.96M | 3.16M | 20.05M | 16.35M | 8.68M | 21.73M | 19.38M | 126K | -27.84M | -51.61B | -46.2B | -47.53B | -17.43B | -7.58B | 2.79B | -9.65B | -12.02M | -5.96M | -3.81M | -2.61M | n/a | n/a | n/a |
| Net Income | -18.52M | 18.78M | -47.9M | -42.6M | -22.55M | 6.09M | 15.49M | -1.08M | 3.93M | 15.38M | 28.75M | 301K | -27.72M | -51.61M | -46.2M | -47.53M | -17.43M | -7.58M | 2.79M | -9.65M | -12.02M | -5.96M | -3.81M | -2.61M | -3.44M | -1.41M | -2.66M |
| Selling & General & Admin | 249.64M | 161.7M | 124.04M | 84.29M | 64.99M | 55.84M | 44.06M | 31.58M | 27.83M | 21.16M | 17.93M | 16.39M | 8.23M | 6.98M | 5.94M | 5.67M | 5.96M | 4.33M | 7.03M | 3.05M | 3.08M | 2.33M | 1.77M | 2.3M | 1.68M | 853.39K | 1.11M |
| Research & Development | 44.58M | 34.29M | 22.32M | 11.37M | 16M | 19.81M | 15.39M | 9.07M | 2.91M | 2.87M | 2.68M | 1.71M | 16.89M | 44.18M | 39.71M | 13.68M | 15.79M | 4.75M | 3.86M | 6.41M | 9.16M | 3.69M | 4.79M | 2.14M | 1.89M | 660.59K | 1.4M |
| Other Expenses | 319.57M | 62.35M | 56.97M | 48.03M | 55.9M | 51.32M | -550K | 55K | -74K | 41K | 160K | -305K | 353.95K | 148.24K | 167.99K | 20.33M | 43.14K | 89.82K | 117.78K | 100.94K | 101.94K | 92.93K | 92.1K | 92.56K | 122.79K | 90.97K | 269.7K |
| Operating Expenses | 613.79M | 258.33M | 203.33M | 143.69M | 136.89M | 126.97M | 93.19M | 68.58M | 53.08M | 30.93M | 24.49M | 19.21M | 25.47M | 51.31M | 45.81M | 39.68M | 21.79M | 9.17M | 11M | 9.56M | 12.34M | 6.11M | 6.64M | 4.53M | 3.69M | 1.6M | 2.78M |
| Interest Expense | 17.6M | 26.94M | 28.05M | 11.92M | 9.45M | 12.97M | 14.76M | 12.04M | 11.33M | 11.01M | 787K | 467K | 348.02K | 681.57K | 688.08K | 147.03K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 613.79M | 439.85M | 342.12M | 244.31M | 224.04M | 190.12M | 166.22M | 147.61M | 101.86M | 43.62M | 35.96M | 29.18M | 25.47M | 51.36M | 46.08M | 39.68M | 21.79M | 9.17M | 11M | 9.56M | 12.34M | 6.11M | 6.64M | 4.53M | 3.66M | 1.6M | 2.78M |
| Income Tax | -3.69M | 1.09M | -14.77M | -13.46M | -3.41M | -2.94M | 4.56M | 17.43M | 4.74M | 6.36M | -9.37M | 20K | -121.79K | 681.67K | 2.59M | 9.1M | -17.41B | -7.58B | 648.49K | 348.81K | n/a | n/a | n/a | n/a | -227.72K | -198.68K | n/a |
| Shares Outstanding (Basic) | 19.32M | 18M | 16.26M | 12.6M | 11.96M | 11.84M | 11.68M | 11.55M | 11.45M | 11.37M | 10.94M | 5.07M | 3.63M | 2.73M | 1.83M | 943.11K | 758.54K | 707.93K | 588.64K | 538.67K | 476.26K | 306.63K | 208.42K | 180.15K | 159.82K | 137.29K | 96.83K |
| Shares Outstanding (Diluted) | 19.32M | 18.19M | 16.26M | 12.6M | 11.96M | 12.04M | 11.77M | 11.55M | 11.57M | 11.56M | 11.05M | 5.07M | 3.63M | 2.73M | 1.83M | 943.11K | 758.54K | 707.93K | 596.78K | 538.67K | 476.26K | 306.63K | 208.42K | 180.15K | 159.82K | 137.29K | 96.83K |
| EPS (Basic) | -0.87 | 0.95 | -2.95 | -3.38 | -1.88 | 0.51 | 1.33 | -0.09 | 0.34 | 1.34 | 2.61 | -0.92 | -7.64 | -18.88 | -25.23 | -50.39 | -22.97 | -10.71 | 4.68 | -17.92 | -25.23 | -19.44 | -18.28 | -14.5 | -21.51 | -10.24 | -27.47 |
| EPS (Diluted) | -0.87 | 0.94 | -2.95 | -3.38 | -1.88 | 0.50 | 1.32 | -0.09 | 0.34 | 1.32 | 2.59 | -0.92 | -7.64 | -18.88 | -25.23 | -50.39 | -22.97 | -10.71 | 4.68 | -17.92 | -25.23 | -19.44 | -18.28 | -14.5 | -21.51 | -10.24 | -27.47 |
| EBITDA | 63.12M | 106.6M | 48.07M | -1.68M | 29.07M | 60.73M | 69.1M | 57.16M | 56.31M | 39.64M | 24.04M | 7.51M | -27.23M | -50.78M | -45.34M | -47.24M | -17.38M | -7.49M | 3.56M | -9.55M | -11.91M | -5.95M | -3.72M | -2.68M | -3.31M | -1.51M | -2.52M |
| Depreciation & Amortization | 67.73M | 59.79M | 56.97M | 47.25M | 44.64M | 44.61M | 33.74M | 27.93M | 22.34M | 6.9M | 3.88M | 1.11M | 258.95K | 148.24K | 167.99K | 137.28K | 43.14K | 89.82K | 117.78K | 100.94K | 101.94K | 92.93K | 92.1K | 110.56K | 122.79K | 90.97K | 139.77K |